Singapore markets closed

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
409.05+0.09 (+0.02%)
As of 09:53AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close408.96
Bid409.36 x 800
Ask411.94 x 800
Day's range406.99 - 412.48
52-week range317.06 - 664.70
Avg. volume513,138
Market cap33.876B
Beta (5Y monthly)1.14
PE ratio (TTM)53.54
EPS (TTM)7.64
Earnings date31 Jan 2023 - 06 Feb 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est480.63
  • Zacks

    IDEXX (IDXX) Q3 Earnings Beat Estimates, 2022 EPS View Down

    IDEXX's (IDXX) Q3 top-line performance rides on strong CAG Diagnostics recurring revenue growth.

  • Motley Fool

    Why IDEXX Stock Popped Today

    Shares of IDEXX Laboratories (NASDAQ: IDXX) were moving higher today after the veterinary healthcare company posted better-than-expected results in its third-quarter earnings but slashed its full-year earnings guidance due to the stronger dollar and higher interest rates. The company said overall revenue was up 4% in the quarter to $841.7 million, but organic sales, which adjust for currency headwinds, increased 8%. Organic revenue in U.S. pet diagnostics, its biggest business segment, was up 10%, and the company saw 14% growth in its global premium installed instrument base, which bodes well for future sales.

  • Zacks

    Idexx Laboratories (IDXX) Beats Q3 Earnings and Revenue Estimates

    Idexx (IDXX) delivered earnings and revenue surprises of 5.39% and 1.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?